First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.
Saved in:
| Title: | First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. |
|---|---|
| Authors: | Agarwal R (AUTHOR), Gourley C (AUTHOR), Perren TJ (AUTHOR), Reed N (AUTHOR), Parkin DE (AUTHOR), Carty K (AUTHOR), Rustin GJS (AUTHOR), Gabra H (AUTHOR), Paul J (AUTHOR), Gore ME (AUTHOR), Kaye SB (AUTHOR), Scottish Gynecological Cancers Trials Group (CORPORATE AUTHOR) |
| Source: | European Journal of Cancer. Jul2010, Vol. 46 Issue 11, p2020-2026. 7p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 105069094 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Agarwal+R%22">Agarwal R</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gourley+C%22">Gourley C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perren+TJ%22">Perren TJ</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reed+N%22">Reed N</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Parkin+DE%22">Parkin DE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carty+K%22">Carty K</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rustin+GJS%22">Rustin GJS</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gabra+H%22">Gabra H</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Paul+J%22">Paul J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gore+ME%22">Gore ME</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaye+SB%22">Kaye SB</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scottish+Gynecological+Cancers+Trials+Group%22">Scottish Gynecological Cancers Trials Group</searchLink> (CORPORATE AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. Jul2010, Vol. 46 Issue 11, p2020-2026. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=105069094 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2010.03.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 2020 Titles: – TitleFull: First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Agarwal R – PersonEntity: Name: NameFull: Gourley C – PersonEntity: Name: NameFull: Perren TJ – PersonEntity: Name: NameFull: Reed N – PersonEntity: Name: NameFull: Parkin DE – PersonEntity: Name: NameFull: Carty K – PersonEntity: Name: NameFull: Rustin GJS – PersonEntity: Name: NameFull: Gabra H – PersonEntity: Name: NameFull: Paul J – PersonEntity: Name: NameFull: Gore ME – PersonEntity: Name: NameFull: Kaye SB – PersonEntity: Name: NameFull: Scottish Gynecological Cancers Trials Group IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 07 Text: Jul2010 Type: published Y: 2010 Identifiers: – Type: issn-print Value: 09598049 Numbering: – Type: volume Value: 46 – Type: issue Value: 11 Titles: – TitleFull: European Journal of Cancer Type: main |
| ResultId | 1 |
